DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Mylan Inc. (NASDAQ: MYL)

70.12 0.42 (0.60%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MYL $70.12 0.60%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $69.67
Previous Close $69.70
Daily Range $69.34 - $70.41
52-Week Range $44.80 - $76.69
Market Cap $34.4B
P/E Ratio 32.17
Dividend (Yield) $0.00 (0.0%)
Volume 2,574,521
Average Daily Volume 4,957,565
Current FY EPS $4.12




Drug Makers

Mylan Inc. (MYL) Description

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients. Website:

News & Commentary Rss Feed

Billionaire George Soros Just Sold These 3 Stocks: Should You?

The Soros Fund Management sold Kite Pharma, Valeant Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. in the first quarter. Should you follow in its footsteps?

Mergers and Acquisitions Boom Will Keep Rolling as Interest Rates Rise

Premarket Biotech Digest: Gilead Files TAF NDA, Pristiq Goes Generic, Biocept Surges 7%

Top Takeaways From BMO's Specialty Pharma Day

S&P 500 Analyst Moves: MYL

Perrigo's Promising Future: 3 Compelling Reasons To Invest In Perrigo Company

Gilead Patent for Sovaldi Rejected in China, Shares Down - Analyst Blog

Teva Announces Acquisition of 4.61% Interest in Mylan - Analyst Blog

Teva Announces Acquisition of 4.61% Interest in Mylan - Analyst Blog

4 Top S&P 500 Stocks to Buy Not Domiciled in the US

5 Top ADSs Seeing Big Analyst Upgrades and Downgrades

Mylan Inks Deal with Pulmatrix for Respiratory Disease Drug - Analyst Blog

See More MYL News...

MYL's Top Competitors

MYL $70.12 (0.60%)
Current stock: MYL
JNJ $98.44 (-0.03%)
Current stock: JNJ
NVS $99.80 (1.30%)
Current stock: NVS
RHHBY $35.18 (0.10%)
Current stock: RHHBY